The Society of Interventional Radiology (SIR) has submitted comments to the Centers for Medicare and Medicaid Services (CMS) recommending changes to its April 27 2016 Quality Payment Program proposed rule.
Ask4UFE.com, a website created to educate women about fibroid treatment options including uterine fibroid embolization, recently relaunched making it easier for patients to find a physician in their area.
For older patients with small (T1a) renal cancer, percutaneous ablation is associated with much lower costs than partial or radical nephrectomy, both at the time of treatment and through the first year after treatment, new research has shown.
Bluegrass Vascular has announced receiving CE mark approval for the Surfacer Inside-Out access catheter system, indicated for obtaining central venous access to facilitate catheter insertion into the central venous system via a novel “Inside-Out” approach. The company is also launching a limited commercial sale of the system.
A new study, based on patient-reported outcomes, published online ahead of print on 17 August in JAMA Surgery reports that patients with intermittent claudication who received a revascularisation intervention (either endovascular or surgical) had significantly improved function, better health-related quality of life and fewer symptoms at 12 months compared with those who received medical management.
On 17 August, a multicentre, randomised, double-blind, placebo-controlled trial—the VAPOUR trial—was published online ahead of print in The Lancet. Six-month data from the trial provide the first sham-controlled evidence in support of using the procedure.
Insightec has announced that Exablate, which uses magnetic resonance-guided focused ultrasound (MRgFUS), for pain palliation of bone metastases in cancer patients is now a covered benefit for members of a major health insurance provider in the USA. The procedure is non-invasive and uses no radiation to control painful metastases.
The US Food and Drug Administration has announced that Dutch company DSM Biomedical BV—Cook Medical’s supplier of hydrophilic coating for the Roadrunner Uniglide hydrophilic wire guide, has recalled certain lots of material due to concerns about a potential contamination by glass particles ranging in size of approximately 4–280µm.
The first use of Endologix’s Ovation Alto abdominal stent graft system has been reported in two patients with abdominal aortic aneurysms (AAA). The patients were treated by Andrew Holden and Andrew Hill of Auckland City Hospital, Auckland, New Zealand.
European Society for Medical Oncology (ESMO) has released new consensus guidelines for the management of metastatic colorectal cancer that reflect an increasingly personalised approach to treatment, as published online recently in Annals of Oncology.
Percutaneous intra-articular pulsed radiofrequency neurolysis seems to be an effective and safe technique in the palliative management of chronic pain in patients with knee osteoarthritis, found research presented at the Society of Interventional Radiology annual scientific meeting in Vancouver, earlier this year.
Marianne Brodmann, Medical University Graz, Austria, presented the final 12-month results of the ILLUMENATE European randomised clinical trial at the Amputation Prevention Symposium in Chicago, USA.
Incomplete tumour treatment and local tumour progression remain important limitations to the widespread use of radiofrequency ablation for colorectal liver metastases. This means it is vital to develop and apply prognostic markers to identify patients at increased risk for local tumour progression after ablation. A new study, recently published in Radiology, finds that biopsy of the ablation zone after ablation is feasible.
The UK National Institute for Health and Care Excellence (NICE) has developed a Medtech Innovation Briefing (MIB) on the Lutonix drug-coated balloon (DCB) for peripheral arterial disease. Lutonix (Bard) is a paclitaxel-coated percutaneous transluminal angioplasty catheter indicated for treating peripheral arterial disease.
The Interventional Initiative, Oakland, USA and Evolve Media Production, San Francisco and New York, USA, have announced the distribution of episode one of the documentary “Without a Scalpel” on Amazon Prime and Vimeo On Demand.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos